Table 1.
Element | Humanistic studies | Economic studies |
---|---|---|
Patients |
Individuals of any age with immunoglobulin A nephropathy (IgAN) Studies reporting a mixed population were excluded unless data were reported separately for patients with IgAN |
|
Interventions | Any or no intervention | |
Comparison | Any or no comparators | |
Outcomes |
Any HRQoL measure Any health state utility Any utility mapping algorithms |
Direct costs Indirect costs Cost–benefit outcomes Cost–utility outcomes Cost-effectiveness outcomes Cost-minimization outcomes Budget impact analyses Healthcare resource use |
Study designs |
Systematic reviews conducted in the most recent 5 years (for record checking only) Prospective clinical trials (phases I–IV) Observational studies Cost–utility analyses Utility elicitation studies Utility mapping studies Exclude: Case reports Nonsystematic reviews |
Systematic reviews conducted in the most recent 5 years (for record checking only) Economic evaluations (cost–benefit analyses, cost-effectiveness analyses, cost–utility analyses, cost-minimization analyses) Prospective clinical trials (Phases I to IV) Observational studies Budget impact analyses Costing and resource use studies |
Publication timeframe | Studies published from 1980 onward | Studies published from 2011 onward |
Geographic limitations | None | |
Language | English language abstract and full text. | |
Databases to search |
PubMed Ovid Embase Cochrane Database of Systematic Reviews (Cochrane Library) Cochrane CENTRAL database (Cochrane Library) ClinicalTrials.gov International Clinical Trials Registry Platform (ICTRP) NHS Economic Evaluations Database (NHS EED) CEA register ScHARR Health Utilities Database Database of Abstracts of Reviews of Effects (DARE) |
|
Other search approaches |
Searches of the following conferences for the period 2019–2021: American Society of Nephrology (ASN) The European Renal Association–European Dialysis and Transplant Association (ERA–EDTA) International Society of Nephrology (ISN) The Professional Society of Health Economics and Outcomes Research (ISPOR) UK Kidney Week National Kidney Foundation meetings Checking the reference lists of relevant systematic reviews published in the last 5 years Checking the reference lists of included studies |
CEA cost-effectiveness analysis, eGFR estimated glomerular filtration rate, HRQoL health-related quality of life, IgAN Immunoglobulin A nephropathy